Khadijah A Altammar
Biographic Data
| ID | 7931243 |
|---|---|
| NAME | Khadijah A Altammar |
| GIVEN NAMES | Khadijah A |
| FAMILY NAME | Altammar |
| SIGNATURE | ALTAMMAR K A |
| AFFILIATIONS | University of Hafr Al-Batin |
| ORCID | 0000-0002-8691-086X |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Potential Therapeutic Candidates against Chlamydia pneumonia Discovered and Developed In Silico Using Core Proteomics and Molecular Docking and Simulation-Based Approaches
Chlamydia pneumonia, a species of the family Chlamydiacea, is a leading cause of pneumonia. Failure to eradicate C. pneumoniae can lead to chronic infection, which is why it is also considered responsible for chronic inflammatory disorders such as asthma, arthritis, etc. There is an urgent need to tackle the major concerns arising due to persistent infections caused by C. pneumoniae as no FDA-approved drug is available against this chronic infect…
No prominent works on this page.
Potential Therapeutic Candidates against Chlamydia pneumonia Discovered and Developed In Silico Using Core Proteomics and Molecular Docking and Simulation-Based Approaches
Chlamydia pneumonia, a species of the family Chlamydiacea, is a leading cause of pneumonia. Failure to eradicate C. pneumoniae can lead to chronic infection, which is why it is also considered responsible for chronic inflammatory disorders such as asthma, arthritis, etc. There is an urgent need to tackle the major concerns arising due to persistent infections caused by C. pneumoniae as no FDA-approved drug is available against this chronic infect…
Bioinformatics (1 work) · Biology (1 work) · Computational biology (1 work) · Docking (animal (1 work) · Drug Discovery (1 work) · Enzyme Structure and Function (1 work) · Gene (1 work) · Genetics (1 work) · In silico (1 work) · Medicine (1 work)